OpenVSafe by OpenVAERS
Search V-safe

K5E-20382-44126

1 vaccination 1 coded response 3 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
952 / CA
Registered
2021-09-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-08-31
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-09-01
    Registered in v-safe
  3. 2021-09-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenia, Mobility decreased — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Weakness, can barely get out of bed
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  4. 2021-09-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain
    Adult check-in
  5. 2021-09-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-08-31Janssen/Johnson & Johnson No

Free text

Release 9 — days 1–6 daily, dose 1

2021-09-01

Systemic reaction (other): Weakness, can barely get out of bed

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROAsthenia ✓ · ✓
SROMobility decreased ✓ · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release